 |
Partners' Directory |
| Home Search Join the Partnership Login | |
| Contact | General | Specializations in Countries | Contribution to the Global Plan | Declaration |
View this partner's profile
Organization Contact Information | |
| Name: | Africa for Health Research Initiative (AHR-Uganda) |
| Street 1: | Lwanika Road, Buyemba center |
| Street 2: | |
| City: | Mayuge |
| Province: | |
| Post Code: | +256 |
| Country: | Uganda |
| Phone: | +256759576832 |
| Organization Email: | ahr@ahruganda.org |
| Web Site: | http://www.ahruganda.org |
| Other Online Presence: | |
|
|
||||||||||||||||||||||||||||
General Information | |
| Board Constituency: | Developing Country NGO |
| Is your organization legally registered in your country: | Yes |
| If yes, please enter your registration number: | |
| Organization Type - Primary: | Non-Governmental Organization |
| Organization Type - Secondary: | Community-Based Organization (CBO) |
| Organization Description: | |
| Africa for Health Research Initiative is a Community- based Pressure group formed in 2010 with the aim of drumming up the importance of health research to African communities, specifically on HIV/AIDS, Tuberculosis and Malaria. It is dedicated to supporting health Research through training and sensitizing communities on the importance of Health Research, reminding researchers on the importance of effective community involvement in the health research agenda and challenging governments to priotize health research through advocacy. It was founded by a group of activists who after spending several years in Public Health Service in rural Africa, appreciated that there was an urgent need for an enhanced evidence base for novel prevention strategies, treatment regimens and standard of care for the three Africa’s deadliest killers – HIV/AIDS, Tuberculosis and Malaria. |
|
| Do you know about the UNHLM declaration: | |
Specializations / Areas of Work | |
|
Advocacy Research and Development Technical Assistance |
Other Organization Information | |
| Total number of staff in your organization: | 6 - 10 |
| Number of full-time staff who are directly involved with TB: | 6 - 10 |
| Number of part-time staff who are directly involved with TB: | 11 - 25 |
| Number of volunteers who are directly involved with TB: | 26 - 50 |
| How did you hear about the Stop TB Partnership: | Involvement in TB control provision |
| If you were informed or referred by another partner of the Stop TB Partnership please tell us who: | |
| Why do you wish join the Stop TB Partnership: | Involvement in Stop TB Working Groups |
| Are you a member of a Stop TB national partnership: | Uganda |
| Are you in contact with your national TB programme: | Yes |
| Please tell us how your organization is contributing to your country's national TB control plan: | |
| AHR Uganda is a member of the national Stop Tb Partnership and therefore working with others to scale up TB infection control and intensify case detection and treatment. We have also taken up educating communities to appreciate the importance and support for new TB tools namely: New Drugs, New Vaccines and New Diagnostics. | |
Geographical Reach | |
| Which country is your headquarters located in: | Uganda |
| Which countries do you do operate in: (This includes countries you are conducting activities in) |
Uganda |
Contribution | |
| Please tell us how your organization will contribute to the Global Plan to Stop TB by briefly describing its involvement in any of the areas of work listed below: | |
|
TB-HIV: We are advocating for integration of TB and HIV services under the same roofs our national Health care facilities. We recognise that TB is the leading killer of People Living with HIV in our communities and therefore the latter cannot be managed in isolation of the former. New Diagnostics: We are advocating for a point - of - care- test for TB in our communities. This we shall achieve by creating an enabling environment for research in New diagonistics as well as participating in operational research. New TB Drugs: We are advocating for research into new effective short term TB drugs and ultimately making them accessible to the communities. New TB Vaccines: We are involved in educating the communities on the importance of having a new better TB vaccine that is effective to all populations and affordable to those who need it most. we ask community members to participate in TB vaccines clinical trials; remind researchers on the importance of effective community involvement in research and advocate to our governments to priotise research in TB Research: We are involved in conducting operational research with the aim of establishing the best ways of up-taking the existing TB tools like Vaccines, Drugs and diagnostics as well as in preparation for the new ones that are in the pipeline. |
|
Declaration | |
| Declaration of interests: No conflicts of interest were delacred. | |
| Application date: | June 18, 2011 |
| Last updated: | April 24, 2024 |